This chapter describes the patent component of the conflict between the TRIPS Agreement and access to medicine. It provides the necessary background in patent law, its history, and rationales and then describes the obligations the TRIPS Agreement imposes on WTO Members. It shows that the lack of jurisprudence leaves many of the details of the obligations imprecise. However, Members clearly have to provide for 20-year product patents in the pharmaceutical area.
Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
If you think you should have access to this title, please contact your librarian.